Evgenii Shumilov

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany

Christine Eisfeld, Hiltraud Kajüter, Lennart Möller et al. · BMC Cancer · 2023 · 57 citations · Full text

Public Health, Biostatistics, Oncology +16

Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndrome

Thomas Pabst, Raphael Joncourt, Evgenii Shumilov et al. · Experimental Hematology · 2020 · 45 citations · Full text

Life Sciences, Immunology, Cellular Immunology +15

Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

Philipp Berning, Evgenii Shumilov, Markus Maulhardt et al. · HemaSphere · 2024 · 33 citations · Full text

Medicine, Hematology, Oncology +16

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton‐García, Francesco Marchesi, Francesca Farina et al. · EClinicalMedicine · 2024 · 32 citations · Full text

Medicine, Infectious Diseases, Epidemiology +6